Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $4.38 million. The enterprise value is -$10.77 million.
| Market Cap | 4.38M |
| Enterprise Value | -10.77M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 7.58 million shares outstanding. The number of shares has increased by 202.21% in one year.
| Current Share Class | 6.73M |
| Shares Outstanding | 7.58M |
| Shares Change (YoY) | +202.21% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 19.98% |
| Float | 5.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.97
| Current Ratio | 1.97 |
| Quick Ratio | 1.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.12% and return on invested capital (ROIC) is -42.18%.
| Return on Equity (ROE) | -58.12% |
| Return on Assets (ROA) | -15.36% |
| Return on Invested Capital (ROIC) | -42.18% |
| Return on Capital Employed (ROCE) | -45.77% |
| Weighted Average Cost of Capital (WACC) | 15.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$758,250 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.93% in the last 52 weeks. The beta is 2.05, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | -64.93% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 43.65 |
| Average Volume (20 Days) | 30,299 |
Short Selling Information
The latest short interest is 55,145, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 55,145 |
| Short Previous Month | 60,867 |
| Short % of Shares Out | 0.73% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.52M |
| Pretax Income | -3.03M |
| Net Income | -3.03M |
| EBITDA | -3.51M |
| EBIT | -3.52M |
| Earnings Per Share (EPS) | -$0.46 |
Balance Sheet
The company has $15.15 million in cash and no debt, with a net cash position of $15.15 million or $2.00 per share.
| Cash & Cash Equivalents | 15.15M |
| Total Debt | n/a |
| Net Cash | 15.15M |
| Net Cash Per Share | $2.00 |
| Equity (Book Value) | 7.55M |
| Book Value Per Share | 1.00 |
| Working Capital | 7.70M |
Cash Flow
| Operating Cash Flow | -4.51M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 17,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.51M |
| FCF Per Share | -$0.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Mustang Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -202.21% |
| Shareholder Yield | -202.21% |
| Earnings Yield | -69.17% |
| FCF Yield | -102.88% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 16, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | Jan 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |